Medline Namic Syringes Recall Over Regulatory Issues

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Medline Industries is recalling 24,170 units of Namic Syringes due to rescinded 510(k) regulatory clearances, affecting medical devices distributed nationwide.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on May 7, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.

What Happened

Medline Industries, LP is recalling certain lots of Medline Namic Syringes because the 510(k) regulatory clearances for these control syringes have been rescinded.

Which Products Are Affected

The affected products are Medline Namic Syringes with Model Number: DYNJSYR10CWRB. The recall involves 24,170 units distributed US Nationwide. Specific details include UDI-DI: 10889942540570 (each), 40889942540571 (case), and Lot Numbers: 25GBK394, 25GBN659, 25GBO446, 25GBO586, and 25GBQ523. The recall number is Z-1830-2026.

What You Should Do

Consumers and users should refer to the letter from Medline Industries for instructions on this voluntary recall.

Why This Matters

This recall affects medical devices used in healthcare, potentially impacting their regulatory compliance and safety for patients.

Source

Information from the FDA recall notice: FDA Recall Number Z-1830-2026 (attribution to FDA).

Original source: FDA Official Notice ↗

All FDA Recalls →

Nationwide notices with similar length or severity timing 8

Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Medline Industries is recalling 24,170 units of Namic Syringes due to rescinded 510(k) regulatory clearances, affecting medical devices distributed nationwide.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.